家庭输液服务市场按交付方式、最终用户、给药途径、服务类型和治疗类型划分－2025-2032年全球预测

预计到 2032 年，家庭输液服务市场规模将达到 524.9 亿美元，复合年增长率为 10.12%。

主要市场统计数据
基准年 2024	242.6亿美元
预计年份：2025年	267.2亿美元
预测年份：2032年	524.9亿美元
复合年增长率 (%)	10.12%

本文简要概述了临床进展、实践创新和支付方动态如何重塑整个护理过程中的家庭输液服务。

随着临床复杂性的增加，居家输液服务正迅速发展，越来越多的患者需要从传统的住院转向居家治疗。输液疗法的进步，加上输液设备便携性的提高和报销管道的拓展，使得门诊和家庭静脉及皮下输液治疗日益成为综合患者照护的重要组成部分。医疗服务提供者正在积极调整其照护模式，在确保安全性、连续性和成本效益的同时，维持与机构照护相当的临床绩效标准。

因此，临床、营运和支付方等各相关人员正在重新评估输液服务的委託和交付方式。临床医生正在整合远端监测和远端医疗，以支援护理和药物管理工作流程；同时，管理人员正在与专科药房和配药机构建立伙伴关係，以确保无菌产品的供应。因此，决策者在设计可扩展的家庭输液项目时，必须同时考虑临床能力、供应链的稳健性和监管合规性。

数位医疗、小型输液技术和监管调整将如何推动输液护理模式模式转移

随着技术创新、监管调整和患者偏好的融合，输液治疗服务模式正在改变。居家医疗不再是小众选择，而是逐渐成为策略性整合方案，旨在减少住院次数并改善病患体验。小型门诊输液帮浦和皮下给药技术的应用，以及病患教育和远距临床监测的改进，正在拓展可在院外安全实施的治疗方法范围。

同时，法律规范也在进行调整，以支持分散式医疗模式，强调品质指标、安全配药规范和临床记录互通性。这种转变正在推动医院、门诊诊所和居家医疗机构之间的整合，从而奖励那些优先考虑医疗连续性和降低再入院风险的医疗管道。因此，医疗领导者正在投资于人才培养、数位监测和流程标准化，以落实这项转型并确保患者获得一致的治疗效果。

美国不断变化的关税措施对家庭输液服务提供者和临床项目的设备和耗材供应链的累积营运影响。

2025年的关税调整正在对输液护理供应链产生波动，影响输液帮浦、耗材和无菌配製材料的采购。进口医疗设备和原料关税的提高，增加了传统上依赖全球化生产布局的医疗机构和供应商的采购复杂性。因此，采购团队正在重新评估其供应商组合和合约结构，以降低关税相关的成本差异和交货延误风险。

为此，各公司正优先考虑供应商多元化、关键零件近岸采购以及策略性库存缓衝，以维持临床服务的连续性。临床负责人正与采购和药房相关人员合作，检验替代设备方案，并确保其与既定的临床方案相容。这些调整正在加速企业对国内製造伙伴关係关係和集中采购策略的兴趣，这些策略旨在减少交易摩擦，并为输液服务提供可预测的供应。

关键细分洞察揭示了交付模式、最终用户环境、管理途径、服务类型和治疗类型如何影响营运和临床策略。

細項分析揭示了不同给药方式、最终用户、给药途径、服务类型和治疗类别在运作和临床方面的差异。给药方式（静脉注射与皮下注射）的差异会影响给药装置的选择、护理师的资格以及监测强度，静脉注射通常需要更密切的监测，而皮下注射则更适合门诊病人给药。诊所、居家医疗机构和医院的最终用户各不相同，因此需要协调不同的人员配备模式、资格认证程序和物流网络，以促进有效的护理交接。

给药途径分为中心途径和周边途径，影响血管通路管理、感染预防通讯协定和病患教育的重点。服务类型包括药房服务、护理服务和病患监测，形成一个整合的服务架构，其中无菌製剂的品质直接影响护理工作流程效率和远距监护系统。例如，抗生素输注使用具有不同药物动力学和安全性特征的药物，如Aminoglycosides、β-内酰胺类和Fluoroquinolones。肿瘤治疗区分静脉注射都需要独特的输注方案和毒性管理。疼痛管理分为非鸦片类药物输注和鸦片类药物输注，每种输注方式都需要不同的法律规范和监测方案。肠外营养分为週边肠外营养和全肠外营养，每种肠外营养都需要不同的代谢监测和导管注意事项。

综上所述，这些细分因素指导医疗服务提供者如何设计临床通讯协定、分配设备和配药能力所需的资金，以及如何配置符合支付方要求和以患者为中心的治疗方案。因此，相关人员必须使其营运模式和品质保证机制与交付模式、最终用户环境、给药途径、服务类型和治疗特征等因素的交汇点相匹配，以确保安全、高效且以患者为中心的输液治疗。

亚太、欧洲、中东和非洲地区的区域机会和限制将决定采用通路和营运规模。

区域动态正在再形成美洲、欧洲、中东和非洲以及亚太地区家庭输液服务的普及和扩展。在美洲，门诊病人报销框架和与现有居家医疗基础设施相协调的监管政策正在推动输液服务的快速普及，而人口老龄化和慢性病患病率的上升则持续推高了对门诊护理的需求。同时，在欧洲、中东和非洲，由于报销体系和医疗服务结构的差异，情况呈现出明显的多样性。一些国家优先发展集中式医院服务，而另一些国家则在试行由远端医疗和社区护理网络支援的分散式输液服务。

在亚太地区，国内医疗器材製造业的快速发展、私人医疗机构的扩张以及对数位医疗平台投资的不断增长，使得居家输液护理得以广泛普及，但监管标准和劳动力的差异可能会限制其统一推广。供应链弹性、器材核准时间以及区域配药能力等方面的差异，都会影响居家输液模式整合的速度与规模。因此，为了成功营运居家输液项目，区域策略必须考虑支付方结构、劳动力准备以及监管协调性。

策略伙伴关係、对认证的重视以及数位化赋能如何塑造输液生态系统中各公司的竞争差异化与能力发展

家庭输液生态系统的企业级动态以策略联盟、差异化能力以及对临床和供应链能力的定向投资为特征。医疗服务提供者正与专科药房、设备製造商和技术供应商合作，创建整合式护理路径，以减少交接环节并提高护理的连续性。同时，拥有强大数位监测平台的参与企业正透过提供以分析主导的依从性和安全性监测，为护理服务提供补充，从而获得市场认可。

竞争优势通常体现在服务范围、严格的合规性以及提供复杂治疗方法并确保临床疗效一致性的能力。行业领导者优先考虑认证、标准化配药流程和严格的培训项目，以支持更先进的居家输液治疗。此外，投资于与电子健康记录和远端医疗平台互通性的公司能够加强护理协调并减少行政管理方面的摩擦。总之，能够将卓越的临床水平、强大的供应链韧性和数位化应对力相结合，从而支持各种治疗类型和护理环境的机构，在竞争环境中更具优势。

为领导者提供切实可行的营运和策略建议，以确保家庭输液服务的供应弹性、临床能力和报销完整性

产业领导者应采取一系列切实可行的措施，充分利用分散式输液带来的机会，同时保障临床标准和营运连续性。此外，他们还应实施库存管治框架，在不造成不必要资金负担的前提下，维持临床用药的可近性。其次，对人才队伍建立的投入至关重要。临床医生和药房工作人员需要接受标准化的能力培训，内容涵盖血管通路管理、输液装置操作和远端分流通讯协定。

此外，将远端监测和远端医疗整合到核心服务管道中应是优先事项，以支持患者儘早出院并降低再入院风险。将临床、药房和管治职能部门联繫起来的跨职能管理正在加速新治疗方法和新设备的引入，同时确保符合监管要求。最后，支付方和医疗服务提供者应认识到居家输液在以患者为中心的护理中的价值，并合作制定报销模式，以奖励基于结果的合约和风险分担安排，从而奖励高品质和连续性的护理。

透过透明的混合方法，结合相关人员访谈、监管整合和交叉检验，深入了解输液计画的运作。

本报告的调查方法结合了质性访谈、文献综述和检验，以确保研究结果的可靠性和可操作性。主要资讯是透过对临床医生、药房负责人、采购主管和家庭医疗保健经理进行结构化访谈收集的，旨在了解第一线营运挑战和策略重点。此外，还系统地审查了监管指南、设备规格和专业标准，以确保临床建议符合普遍的安全和品质预期。

分析过程包括将访谈主题与观察到的行业倡议和公共变化进行交叉检验，从而在不依赖单一资料来源的情况下识别出新兴模式。在整个过程中，我们始终专注于资料来源并努力减少潜在偏差，确保结果能够平衡地反映相关人员的观点和已记录的实践。这种混合方法的调查方法使我们能够提出切实可行的建议，并深入了解影响家庭输液服务成功部署的各项营运因素。

前瞻性概述重点介绍了临床卓越性、供应链韧性和数位化监控的整合，以实现可持续的居家输液护理。

随着临床能力、数位化监测和病患偏好的日益融合，居家输液服务将在现代医疗服务中发挥越来越重要的作用。医疗保健的成功取决于将无菌产品品质、护理能力和供应链韧性整合到一个连贯的方案中，以满足支付方的期望和监管标准。随着相关人员采用分散式输液管道，对互通性、临床医生培训和病人安全的关注将决定哪些模式能够有效且可持续地扩展。

未来，随着设备小型化、皮下治疗方案的拓展以及远端监测机制的出现，适合居家治疗的疗法范围可望进一步扩大。然而，营运上的谨慎，包括多元化的资源取得、严格的认证以及以疗效为导向的合约签订，对于将临床潜力转化为可靠的、以患者为中心的医疗服务仍然至关重要。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 整合远端医疗平台，用于输液治疗期间的即时远端监测和患者支持
• 采用人工智慧驱动的给药演算法，以优化输液治疗的准确性和安全性
• 扩大报销范围，涵盖专业的居家输液服务，并降低病患的自付费用。
• 利用行动病患监测应用程式和连网输液设备开发个人化依从性方案
• 对复杂的生技药品和肿瘤输液的需求日益增长，这些都需要专门的居家照护基础设施和培训。
• 透过家庭输液服务提供者和专科药房之间的策略伙伴关係，实现端到端的连续性护理
• 实施穿戴式安全感测器和物联网系统，以加强家庭输液风险管理和合规性
• 随着全国性医疗服务提供者透过併购扩大其本地家庭输液网路和能力，市场整合正在加剧。

第六章美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

8. 依交付方式分類的家庭输液服务市场

• 静脉
• 皮下

9. 按最终用户分類的家庭输液服务市场

• 诊所
• 家庭医疗保健机构
• 医院

10. 依管理途径分類的家庭输液服务市场

• 中央静脉
• 週边静脉

第十一章：按服务类型分類的家庭输液服务市场

• 复合服务
• 护理服务
• 病患监测

12. 依治疗类型分類的家庭输液服务市场

• 静脉注射抗生素
  • Aminoglycosides
  • β-内酰胺类
  • Fluoroquinolones
• 肿瘤学
  • 静脉肿瘤治疗
  • 皮下肿瘤治疗
• 疼痛管理
  • 非阿片类药物输注
  • 阿片类药物输注
• 静脉营养
  • 周边静脉营养
  • 全静脉营养

13. 按地区分類的家庭输液服务市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十四章：依群体分類的家庭输液服务市场

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

15. 各国家庭输液服务市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十六章 竞争格局

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • Option Care Health, Inc.
  • CVS Health Corporation
  • InfuSystem Holdings, Inc.
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Fresenius Kabi AG
  • Becton, Dickinson and Company
  • ICU Medical, Inc.
  • Terumo Corporation
  • Nipro Corporation

The Home Infusion Services Market is projected to grow by USD 52.49 billion at a CAGR of 10.12% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 24.26 billion
Estimated Year [2025]	USD 26.72 billion
Forecast Year [2032]	USD 52.49 billion
CAGR (%)	10.12%

A concise orientation to how clinical advances, operational innovations, and payer dynamics are reshaping home infusion delivery across care continuums

The home infusion services landscape is evolving rapidly as clinical complexity shifts care beyond traditional inpatient settings and into patients' homes. Advances in infusion therapeutics, combined with enhanced portability of infusion devices and expanded reimbursement pathways, have made outpatient and home-based intravenous and subcutaneous therapies an increasingly viable component of comprehensive patient care. Providers are responding by reconfiguring care models to prioritize safety, continuity, and cost efficiency while maintaining clinical performance standards comparable to facility-based care.

As a result, stakeholders across clinical, operational, and payer communities are reassessing how infusion services are commissioned and delivered. Clinicians are integrating remote monitoring and telehealth to support nursing and medication administration workflows, whereas administrators are building partnerships with specialty pharmacies and compounding facilities to secure sterile preparations. Consequently, decision-makers must consider clinical competency, supply chain robustness, and regulatory compliance in parallel when designing scalable home infusion programs.

How digital health, compact infusion technologies, and regulatory adaptations collectively drive a paradigm shift toward decentralized infusion care

Care delivery for infusion therapies is undergoing transformative shifts as technological innovation, regulatory adjustments, and patient preferences converge. Home-based care is no longer a niche alternative; it is being embedded as a strategic option to reduce inpatient utilization and to improve patient experience. The adoption of compact ambulatory infusion pumps and subcutaneous administration techniques, alongside improvements in patient education and remote clinical oversight, has expanded the range of therapies that can be safely managed outside the hospital.

Meanwhile, regulatory frameworks are adapting to support decentralized care models, emphasizing quality metrics, safe compounding practices, and interoperability of clinical records. These shifts encourage integration between hospitals, outpatient clinics, and home healthcare entities and create incentives for care pathways that prioritize continuity and reduced readmission risk. In turn, healthcare leaders are investing in workforce training, digital monitoring, and process standardization to operationalize these transformative changes and to ensure consistent patient outcomes.

The cumulative operational consequences of evolving U.S. tariff policy on device and consumable supply chains for home infusion providers and clinical programs

Tariff policy adjustments in 2025 are creating ripples across supply chains that support infusion care, affecting procurement of infusion pumps, disposables, and sterile compounding inputs. Increased duties on imported medical devices and raw materials have raised sourcing complexity for providers and suppliers that historically relied on globalized manufacturing footprints. Consequently, procurement teams are reassessing vendor portfolios and contract structures to mitigate exposure to customs-related cost volatility and delivery delays.

In response, organizations are prioritizing supplier diversification, nearshoring of critical components, and strategic inventory buffering to maintain clinical continuity. Clinical leaders are collaborating with procurement and pharmacy stakeholders to validate alternative device options and to ensure compatibility with established clinical protocols. Over time, these adjustments are accelerating interest in domestic manufacturing partnerships and aggregated purchasing strategies that reduce transactional friction and support predictable supply flows for infusion services.

Critical segmentation insights that demonstrate how delivery mode, end user environment, administration route, service type, and therapy type jointly shape operational and clinical strategies

Segmentation analysis reveals differentiated operational and clinical considerations across delivery modes, end users, administration routes, service types, and therapy categories. Delivery mode distinctions between intravenous and subcutaneous pathways inform device selection, nursing competencies, and monitoring intensity, with intravenous therapies often requiring higher acuity oversight and subcutaneous options enabling broader outpatient administration. End user variation across clinics, home healthcare agencies, and hospitals translates to divergent staffing models, credentialing procedures, and logistical networks that must be coordinated for effective transitions of care.

Route of administration divides into central and peripheral approaches, shaping vascular access management, infection prevention protocols, and patient education priorities. Service types encompassing compounding services, nursing services, and patient monitoring form an integrated service architecture where sterile preparation quality feeds directly into nursing workflow efficiency and remote monitoring systems. Therapy-type groupings-antibiotic infusion, oncology, pain management, and parenteral nutrition-require therapy-specific clinical pathways; for example, antibiotic infusion spans aminoglycosides, beta-lactams, and fluoroquinolones with distinct pharmacokinetic and safety profiles, while oncology care differentiates between intravenous oncology agents and subcutaneous oncology agents, each presenting unique infusion scheduling and toxicity management needs. Pain management segregates into non-opioid and opioid infusion strategies, which necessitate different regulatory oversight and monitoring protocols, and parenteral nutrition splits into peripheral parenteral nutrition and total parenteral nutrition, each with distinct metabolic monitoring and catheter considerations.

Taken together, these segmentation dimensions inform how providers design clinical protocols, allocate capital for devices and compounding capacity, and structure care bundles that align with payer requirements and patient-centered outcomes. Consequently, stakeholders must tailor operational models and quality assurance mechanisms to the specific intersection of delivery mode, end user environment, administration route, service type, and therapy characteristics to ensure safe, efficient, and patient-focused infusion care.

Regional opportunities and constraints across the Americas, Europe Middle East & Africa, and Asia-Pacific that determine adoption pathways and operational scalability

Regional dynamics are reshaping how home infusion services are implemented and scaled, with distinct drivers and constraints across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, regulatory alignment with outpatient reimbursement frameworks and established home health infrastructures supports rapid uptake of infusion services, while population aging and chronic disease prevalence create sustained demand for ambulatory therapy delivery. Meanwhile, Europe, Middle East & Africa displays heterogeneity driven by divergent reimbursement regimes and healthcare delivery structures; some national systems prioritize centralized hospital services while others are piloting decentralized infusion pathways supported by telehealth and community nursing networks.

In Asia-Pacific, rapid development of domestic medical manufacturing, expansion of private healthcare providers, and growing investments in digital health platforms are enabling broader access to home-based infusion care, although variability in regulatory standards and workforce capacity can constrain uniform deployment. Across regions, differences in supply chain resilience, device approval timelines, and local compounding capabilities influence the speed and scale at which home infusion models can be integrated. Therefore, regional strategy must account for payer structures, workforce readiness, and regulatory alignment to successfully operationalize home infusion programs.

How strategic partnerships, accreditation focus, and digital enablement are shaping competitive differentiation and capability development among firms in the infusion ecosystem

Company-level dynamics in the home infusion ecosystem are characterized by strategic collaborations, capability differentiation, and targeted investments in clinical and supply chain capabilities. Providers are forming alliances with specialty compounding pharmacies, device manufacturers, and technology vendors to build integrated care pathways that reduce handoffs and improve continuity. At the same time, entrants with strong digital monitoring platforms are gaining traction by offering analytics-driven adherence and safety oversight that complement nursing services.

Competitive differentiation often centers on service breadth, compliance rigor, and the ability to deliver complex therapies with consistent clinical outcomes. Leaders prioritize accreditation, standardized compounding processes, and rigorous training programs to support higher-acuity home infusions. Additionally, firms that invest in interoperability with electronic health records and telehealth platforms enhance care coordination and reduce administrative friction. In sum, the corporate landscape favors organizations that can combine clinical excellence, supply chain resilience, and digital enablement to support a wide range of therapy types and care settings.

Actionable operational and strategic recommendations for leaders to secure supply resilience, clinical competency, and reimbursement alignment in home infusion services

Industry leaders should adopt a set of pragmatic actions to capitalize on decentralized infusion opportunities while safeguarding clinical standards and operational continuity. First, leaders must institutionalize supplier diversification and nearshore sourcing strategies to mitigate tariff-driven supply disruptions; simultaneously, they should implement inventory governance frameworks that preserve clinical access without creating unnecessary capital burden. Second, investment in workforce development is essential: clinicians and pharmacy staff require standardized competency programs that address vascular access management, infusion device operation, and remote triage protocols.

Moreover, organizations should prioritize integration of remote monitoring and telehealth into core service pathways to support earlier discharge and reduce readmission risk. Cross-functional governance that aligns clinical, pharmacy, and procurement functions will accelerate adoption of new therapies and devices while ensuring regulatory compliance. Finally, payers and providers should collaborate on reimbursement models that recognize the value of home infusion in patient-centered care, incentivizing outcomes-focused contracting and shared risk arrangements that reward quality and continuity of care.

Transparent mixed-methods approach combining stakeholder interviews, regulatory synthesis, and cross-validation to produce reliable operational insights for infusion programs

The research methodology underpinning this report integrates primary qualitative interviews, secondary document synthesis, and triangulated validation to ensure robust, actionable findings. Primary inputs were gathered through structured interviews with clinicians, pharmacy leaders, procurement executives, and home healthcare administrators to capture frontline operational challenges and strategic priorities. These insights were supplemented by a systematic review of regulatory guidance, device specifications, and professional standards to ensure clinical recommendations align with prevailing safety and quality expectations.

Analytical processes included cross-validation of interview themes with observed industry initiatives and public policy shifts, enabling identification of emergent patterns without relying on singular data sources. Throughout the process, careful attention was given to data provenance and potential bias mitigation, ensuring that findings reflect a balanced synthesis of stakeholder perspectives and documented practice. This blended methodology supports practical recommendations and a nuanced understanding of operational levers that influence successful deployment of home infusion services.

A forward-looking summary emphasizing integration of clinical excellence, supply chain resilience, and digital monitoring to operationalize sustainable home infusion care

Home infusion services are positioned to play an increasingly central role in modern care delivery as clinical capabilities, digital monitoring, and patient preferences continue to align. Success will depend on the ability of healthcare organizations to integrate sterile compounding quality, nursing competency, and supply chain resilience into coherent programs that meet payer expectations and regulatory standards. As stakeholders adopt decentralized infusion pathways, emphasis on interoperability, clinician training, and patient safety will determine which models scale effectively and sustainably.

Looking ahead, the convergence of device miniaturization, expanded subcutaneous therapy options, and remote oversight mechanisms will broaden the therapeutic scope suitable for home administration. Nevertheless, operational prudence-manifested as diversified sourcing, rigorous accreditation, and outcome-focused contracting-will remain essential to translating clinical potential into reliable, patient-centered care delivery.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of telehealth platforms for real-time remote monitoring and patient support during infusion therapy
• 5.2. Adoption of artificial intelligence driven dosing algorithms to optimize infusion therapy accuracy and safety
• 5.3. Expansion of reimbursement policies to cover specialized home infusion services and reduce patient out of pocket costs
• 5.4. Development of personalized adherence programs leveraging mobile apps and connected infusion devices for patient monitoring
• 5.5. Rising demand for complex biologics and oncology infusions requiring specialized home care infrastructure and training
• 5.6. Strategic partnerships between home infusion providers and specialty pharmacies for end to end therapeutic continuity
• 5.7. Implementation of wearable safety sensors and IoT systems to enhance at home infusion risk management and compliance
• 5.8. Market consolidation through mergers and acquisitions as national providers expand regional home infusion networks and capabilities

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Home Infusion Services Market, by Delivery Mode

• 8.1. Intravenous
• 8.2. Subcutaneous

9. Home Infusion Services Market, by End User

• 9.1. Clinics
• 9.2. Home Healthcare Agencies
• 9.3. Hospitals

10. Home Infusion Services Market, by Route Of Administration

• 10.1. Central
• 10.2. Peripheral

11. Home Infusion Services Market, by Service Type

• 11.1. Compounding Services
• 11.2. Nursing Services
• 11.3. Patient Monitoring

12. Home Infusion Services Market, by Therapy Type

• 12.1. Antibiotic Infusion
  • 12.1.1. Aminoglycosides
  • 12.1.2. Beta Lactams
  • 12.1.3. Fluoroquinolones
• 12.2. Oncology
  • 12.2.1. Intravenous Oncology Agents
  • 12.2.2. Subcutaneous Oncology Agents
• 12.3. Pain Management
  • 12.3.1. Non Opioid Infusion
  • 12.3.2. Opioid Infusion
• 12.4. Parenteral Nutrition
  • 12.4.1. Peripheral Parenteral Nutrition
  • 12.4.2. Total Parenteral Nutrition

13. Home Infusion Services Market, by Region

• 13.1. Americas
  • 13.1.1. North America
  • 13.1.2. Latin America
• 13.2. Europe, Middle East & Africa
  • 13.2.1. Europe
  • 13.2.2. Middle East
  • 13.2.3. Africa
• 13.3. Asia-Pacific

14. Home Infusion Services Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Home Infusion Services Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Share Analysis, 2024
• 16.2. FPNV Positioning Matrix, 2024
• 16.3. Competitive Analysis
  • 16.3.1. Option Care Health, Inc.
  • 16.3.2. CVS Health Corporation
  • 16.3.3. InfuSystem Holdings, Inc.
  • 16.3.4. Baxter International Inc.
  • 16.3.5. B. Braun Melsungen AG
  • 16.3.6. Fresenius Kabi AG
  • 16.3.7. Becton, Dickinson and Company
  • 16.3.8. ICU Medical, Inc.
  • 16.3.9. Terumo Corporation
  • 16.3.10. Nipro Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 13. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 15. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 17. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 19. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 21. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. ASEAN HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. GCC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. EUROPEAN UNION HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. BRICS HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. G7 HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. NATO HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. HOME INFUSION SERVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 30. HOME INFUSION SERVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. HOME INFUSION SERVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL HOME INFUSION SERVICES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOME HEALTHCARE AGENCIES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY CENTRAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY COMPOUNDING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NURSING SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PATIENT MONITORING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY AMINOGLYCOSIDES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY BETA LACTAMS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY FLUOROQUINOLONES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY INTRAVENOUS ONCOLOGY AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY SUBCUTANEOUS ONCOLOGY AGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY NON OPIOID INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY OPIOID INFUSION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY PERIPHERAL PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY TOTAL PARENTERAL NUTRITION, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL HOME INFUSION SERVICES MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 164. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 165. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 166. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 167. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 168. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 169. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 170. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 171. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 172. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 173. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
• TABLE 174. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
• TABLE 175. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
• TABLE 176. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
• TABLE 177. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 178. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 179. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 180. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
• TABLE 181. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
• TABLE 182. AMERICAS HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
• TABLE 183. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 184. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 185. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 186. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 187. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 188. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 189. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 190. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 191. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 192. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 193. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
• TABLE 194. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
• TABLE 195. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
• TABLE 196. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
• TABLE 197. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 198. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 199. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 200. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
• TABLE 201. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
• TABLE 202. NORTH AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
• TABLE 203. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 204. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 205. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 206. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 207. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 208. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 209. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 210. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 211. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 212. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 213. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
• TABLE 214. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
• TABLE 215. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
• TABLE 216. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
• TABLE 217. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 218. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 219. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 220. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
• TABLE 221. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
• TABLE 222. LATIN AMERICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
• TABLE 223. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
• TABLE 224. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
• TABLE 225. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 226. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 227. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 228. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 229. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 230. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 231. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 232. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 233. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
• TABLE 234. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
• TABLE 235. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
• TABLE 236. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
• TABLE 237. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 238. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 239. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 240. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
• TABLE 241. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
• TABLE 242. EUROPE, MIDDLE EAST & AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
• TABLE 243. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 244. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 245. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 246. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 247. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 248. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 249. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 250. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 251. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 252. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 253. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
• TABLE 254. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
• TABLE 255. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
• TABLE 256. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
• TABLE 257. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 258. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 259. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 260. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
• TABLE 261. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
• TABLE 262. EUROPE HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
• TABLE 263. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 264. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 265. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 266. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 267. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 268. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 269. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 270. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 271. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 272. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 273. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
• TABLE 274. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
• TABLE 275. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
• TABLE 276. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
• TABLE 277. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 278. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 279. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 280. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
• TABLE 281. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
• TABLE 282. MIDDLE EAST HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
• TABLE 283. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 284. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 285. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 286. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 287. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 288. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 289. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 290. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 291. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 292. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2025-2032 (USD MILLION)
• TABLE 293. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2018-2024 (USD MILLION)
• TABLE 294. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY THERAPY TYPE, 2025-2032 (USD MILLION)
• TABLE 295. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2018-2024 (USD MILLION)
• TABLE 296. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ANTIBIOTIC INFUSION, 2025-2032 (USD MILLION)
• TABLE 297. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2018-2024 (USD MILLION)
• TABLE 298. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY ONCOLOGY, 2025-2032 (USD MILLION)
• TABLE 299. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2018-2024 (USD MILLION)
• TABLE 300. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PAIN MANAGEMENT, 2025-2032 (USD MILLION)
• TABLE 301. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2018-2024 (USD MILLION)
• TABLE 302. AFRICA HOME INFUSION SERVICES MARKET SIZE, BY PARENTERAL NUTRITION, 2025-2032 (USD MILLION)
• TABLE 303. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 304. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 305. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
• TABLE 306. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY DELIVERY MODE, 2025-2032 (USD MILLION)
• TABLE 307. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 308. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 309. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
• TABLE 310. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2032 (USD MILLION)
• TABLE 311. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
• TABLE 312. ASIA-PACIFIC HOME INFUSION SERVICES MARKET SIZE,